Skip to main content
MedPathMedPath Home
Clinical Trials/KCT0008118
KCT0008118
Recruiting
未知

Whole Genome Sequencing in Solid Cancer

Genome Insight0 sites120 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Genome Insight
Enrollment
120
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
Genome Insight

Eligibility Criteria

Inclusion Criteria

  • •? Patients who consented to the subject consent form and human derived materials consent form
  • •? Patients aged 19 years or older on the date of signing the consent form
  • •? Patients with the ability to give written consent to voluntarily participate in this study
  • •? Patients who can collect specimens through biopsy and surgical procedure
  • •? A patient with histologically confirmed solid cancer or a patient who has cancer findings through imaging and undergoes a biopsy for pathological confirmation

Exclusion Criteria

  • •? Patients who do not understand or do not consent to written consent
  • •? Patients who are unable to obtain sufficient specimens
  • •? Patients who do not consent to genetic testing

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Whole Genome Sequencing in Breast CancerNeoplasms
KCT0008426Genome Insight1,200
Recruiting
Not Applicable
Whole Genome Sequencing i n advanced cancer cohort with clinical targeted sequencing
KCT0007707Ajou University Hospital60
Recruiting
Not Applicable
A study to determine patient specific markers to customize cancer therapy.Health Condition 1: null- Newly Diagnosed or recurrent Leukemia
CTRI/2014/03/004446Mazumdar Shaw Medical Center14
Active, not recruiting
Not Applicable
The usefulness of whole genome sequencing in diagnosis and clinical management of drug-resistant tuberculosis patients in TanzaniaApplication of whole genome sequencing in multidrug resistance tuberculosis patientsInfections and Infestations
ISRCTN14635089Tanzania Commission for Science and Technology153
Not yet recruiting
Not Applicable
Whole-genome sequencing and comprehensive variant analysis of combined hepatocellular-cholangiocarcinoma, cholangiolocellular carcinoma, CK19 positive HCC, and SOX9 positive HCChepatocellular carcinoma
JPRN-UMIN000032493Kyoto University600